Prof. Peter J. Little AM

引用先

	すべて	2020 年以来
引用	15049	7016
h 指標	69	44
i10 指標	212	125

1900

950

475

1425

198619871988198919901991199219931994199519961997199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202542 52 67 59 79 101 94 93 110 87 116 117 108 122 117 107 91 141 138 200 134 214 242 209 303 240 342 448 372 463 627 636 705 781 940 1058 1361 1480 1879 286

オープンアクセス

すべて表示

76 件の論文

20 件の論文

利用可能

利用不可

助成機関の要件に基づく

共著者

Suowen XuUniversity of Science and Technology of China確認したメールアドレス: ustc.edu.cn
Danielle KamatoNational Heart Foundation - Future Leader Fellow and Group Leader, Griffith University; Griffith確認したメールアドレス: griffith.edu.au
Mandy and BallingerGroup Leader, Genetic Cancer Risk, Garvan Institute of Medical Research確認したメールアドレス: garvan.org.au
Hang Thu TaProfessor, Heart Foundation Future Leader Fellow確認したメールアドレス: griffith.edu.au
Rodney DilleyUniversity of Western Australia確認したメールアドレス: uwa.edu.au
Hossein Babaahmadi-RezaeiDepartment of Medical Biochemistry, Ahvaz Jundishapur University of Medical Sciences, Ahvaz Iran確認したメールアドレス: ajums.ac.ir
Rizwana Afroz, PhDPostdoctoral Associate, Yale University, United States確認したメールアドレス: yale.edu
Garry JenningsBaker Heart and Diabetes Institute確認したメールアドレス: baker.edu.au
Anthony DartAlfred Hospital & BakerIDI, Melbourne, Australia確認したメールアドレス: alfred.org.au
Neale CohenBakerIDI Heart and Diabetes Institiute確認したメールアドレス: baker.edu.au
Mohd FarhanPostdoctoral Research Associate at Georgetown University Washington, D.C.確認したメールアドレス: georgetown.edu
Murray EslerSenior Director Baker IDI Heart and Diabetes Institute確認したメールアドレス: bakeridi.edu.au
John R BendDistinguished University Professor, Emeritus of Pathology Western University確認したメールアドレス: schulich.uwo.ca
Susan G. GraySchool of Pharmacy, University of Queensland確認したメールアドレス: uqconnect.edu.au
Jacques PouyssegurIRCAN, Centre A. Lacassagne, University of Nice and Centre Scientifique de Monaco (CSM)確認したメールアドレス: unice.fr
Chris YunProfessor of Medicine, Emory University確認したメールアドレス: emory.edu
Mark DonowitzProfessor of Medicine and Physiology, Johns Hopkins University School of Medicine確認したメールアドレス: jhmi.edu
Margaret Anne BrimbleSchool of Biological Sciences, School of Chemical Sciences, the University of Auckland,確認したメールアドレス: auckland.ac.nz
Karin Agnes JandeleitDepartment of Diabetes, Central Clinical School, Monash University確認したメールアドレス: monash.edu
Grant MorahanCentre for Diabetes Research, Uni of Western Australia, The Harry Perkins Institute for Medical確認したメールアドレス: uwa.edu.au

フォロー

Prof. Peter J. Little AM

School of Pharmacy, The University of Queensland

確認したメールアドレス: uq.edu.au - ホームページ

Diabetes complications atherosclerosis glycosaminoglycans proteoglycans pharmacy practice


タイトル引用回数順公開年順タイトル順	引用先引用先	年
Endothelial dysfunction in atherosclerotic cardiovascular diseases and beyond: from mechanism to pharmacotherapies S Xu, I Ilyas, PJ Little, H Li, D Kamato, X Zheng, S Luo, Z Li, P Liu, J Han, ... Pharmacological reviews 73 (3), 924-967, 2021	736	2021
FOXO signaling pathways as therapeutic targets in cancer M Farhan, H Wang, U Gaur, PJ Little, J Xu, W Zheng International journal of biological sciences 13 (7), 815, 2017	469	2017
Insulin resistance and atherosclerosis J Nigro, N Osman, AM Dart, PJ Little Endocrine reviews 27 (3), 242-259, 2006	462	2006
Cardiovascular actions and therapeutic potential of tanshinone IIA S Gao, Z Liu, H Li, PJ Little, P Liu, S Xu Atherosclerosis 220 (1), 3-10, 2012	398	2012
Transforming growth factor-β signalling: role and consequences of Smad linker region phosphorylation D Kamato, ML Burch, TJ Piva, HB Rezaei, MA Rostam, S Xu, W Zheng, ... Cellular signalling 25 (10), 2017-2024, 2013	329	2013
LOX-1 in atherosclerosis: biological functions and pharmacological modifiers S Xu, S Ogura, J Chen, PJ Little, J Moss, P Liu Cellular and Molecular Life Sciences 70, 2859-2872, 2013	326	2013
Cloning and expression of a rabbit cDNA encoding a serum-activated ethylisopropylamiloride-resistant epithelial Na+/H+ exchanger isoform (NHE-2) CM Tse, SA Levine, CH Yun, MH Montrose, PJ Little, J Pouyssegur, ... Journal of Biological Chemistry 268 (16), 11917-11924, 1993	279	1993
Zinc and cardiovascular disease PJ Little, R Bhattacharya, AE Moreyra, IL Korichneva Nutrition 26 (11-12), 1050-1057, 2010	274	2010
Effect of moderate alcohol upon obstructive sleep apnoea MF Scanlan, T Roebuck, PJ Little, JR Redman, MT Naughton European respiratory journal 16 (5), 909-913, 2000	274	2000
Proteoglycans synthesized by arterial smooth muscle cells in the presence of transforming growth factor-β1 exhibit increased binding to LDLs PJ Little, L Tannock, KL Olin, A Chait, TN Wight Arteriosclerosis, thrombosis, and vascular biology 22 (1), 55-60, 2002	210	2002
Naringenin and naringin in cardiovascular disease prevention: A preclinical review RH Moghaddam, Z Samimi, SZ Moradi, PJ Little, S Xu, MH Farzaei European Journal of Pharmacology 887, 173535, 2020	181	2020
Endothelin-1 signalling in vascular smooth muscle: pathways controlling cellular functions associated with atherosclerosis ME Ivey, N Osman, PJ Little Atherosclerosis 199 (2), 237-247, 2008	180	2008
GLP-1 receptor agonists (GLP-1RAs): cardiovascular actions and therapeutic potential X Ma, Z Liu, I Ilyas, PJ Little, D Kamato, A Sahebka, Z Chen, S Luo, ... International journal of biological sciences 17 (8), 2050, 2021	172	2021
Targeting mechanosensitive transcription factors in atherosclerosis N Niu, S Xu, Y Xu, PJ Little, ZG Jin Trends in pharmacological sciences 40 (4), 253-266, 2019	167	2019
The possible role of the Akt signaling pathway in schizophrenia W Zheng, H Wang, Z Zeng, J Lin, PJ Little, LK Srivastava, R Quirion Brain research 1470, 145-158, 2012	159	2012
Structure, function, pharmacology, and therapeutic potential of the G protein, Gα/q, 11 D Kamato, L Thach, R Bernard, V Chan, W Zheng, H Kaur, M Brimble, ... Frontiers in Cardiovascular Medicine 2, 129046, 2015	157	2015
Impact of sleep apnea on sympathetic nervous system activity in heart failure P Solin, DM Kaye, PJ Little, P Bergin, M Richardson, MT Naughton Chest 123 (4), 1119-1126, 2003	140	2003
Endothelial function and dysfunction: Impact of metformin A Nafisa, SG Gray, Y Cao, T Wang, S Xu, FH Wattoo, M Barras, N Cohen, ... Pharmacology & therapeutics 192, 150-162, 2018	139	2018
Targeting epigenetics and non-coding RNAs in atherosclerosis: from mechanisms to therapeutics S Xu, D Kamato, PJ Little, S Nakagawa, J Pelisek, ZG Jin Pharmacology & therapeutics 196, 15-43, 2019	138	2019
Mechanisms of oxidized LDL-mediated endothelial dysfunction and its consequences for the development of atherosclerosis H Jiang, Y Zhou, SM Nabavi, A Sahebkar, PJ Little, S Xu, J Weng, J Ge Frontiers in Cardiovascular Medicine 9, 925923, 2022	133	2022

現在システムで処理を実行できません。しばらくしてからもう一度お試しください。

論文 1–20

年間引用数

重複した引用

結合された引用

共著者を追加共著者

フォロー

引用先

共著者